Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption.
Saved in:
| Title: | Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. |
|---|---|
| Authors: | Yajima S; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan., Yoshida S; Department of Urology, Institute of Science Tokyo, Tokyo, Japan., Masuda H; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan., Fujii Y; Department of Urology, Institute of Science Tokyo, Tokyo, Japan. |
| Source: | Translational andrology and urology [Transl Androl Urol] 2026 May 30; Vol. 15 (5), pp. 189. Date of Electronic Publication: 2026 May 15. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42293846 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yajima+S%22">Yajima S</searchLink>; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+S%22">Yoshida S</searchLink>; Department of Urology, Institute of Science Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Masuda+H%22">Masuda H</searchLink>; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+Y%22">Fujii Y</searchLink>; Department of Urology, Institute of Science Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581119%22">Translational andrology and urology</searchLink> [Transl Androl Urol] 2026 May 30; Vol. 15 (5), pp. 189. <i>Date of Electronic Publication: </i>2026 May 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Pub%22">AME Pub </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101581119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2223-4691 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222234683%22">22234683 </searchLink><i>NLM ISO Abbreviation: </i>Transl Androl Urol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42293846 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/tau-2026-1-0104 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 189 Titles: – TitleFull: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yajima S – PersonEntity: Name: NameFull: Yoshida S – PersonEntity: Name: NameFull: Masuda H – PersonEntity: Name: NameFull: Fujii Y IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 05 Text: 2026 May 30 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2223-4691 Numbering: – Type: volume Value: 15 – Type: issue Value: 5 Titles: – TitleFull: Translational andrology and urology Type: main |
| ResultId | 1 |
